Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Letter

Unraveling the mechanisms involved in endothelial barrier protective effects of angiopoietin-1 variant MAT.Ang-1

Ru-Yuan Zhang, Dong Min, Jun Wu, Lei Li, Hong-Ping Qu and Yao-Qing Tang*

Author Affiliations

Department of Critical Care Medicine, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

For all author emails, please log on.

Critical Care 2012, 16:466  doi:10.1186/cc11844


See related research by Alfieri et al., http://ccforum.com/content/16/5/R182

Published: 27 November 2012

First paragraph (this article has no abstract)

With great interest we read the recent article by Alfieri and colleagues [1], demonstrating that angiopoietin (Ang)-1 variant MAT.Ang-1 improved endotoxemiainduced microvascular dysfunction and microvascular hyperpermeability. The authors suggested that MAT. Ang-1-induced recovery of microcirculatory tissue perfusion during sepsis is due to preservation of endothelial barrier integrity. To further elucidate the mechanism, they investigated the possibility of involvement of VE-cadherin, a major adherens junctions protein responsible for microvascular leakage in inflammation. They found, however, while there was no change in overall expression of VE-cadherin, MAT.Ang-1 increased VE-cadherin phosphorylation in the treated mice, which appears unable to explain the observed endothelial barrier protective effects of MAT.Ang-1.